Showing results (161-170 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|October 8, 2021
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumabYoshinobu Koguchi, Noriko Iwamoto, Takashi Shimada, et al.Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.Journal for Immunotherapy of Cancer|October 21, 2021
Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastasesBenjamin Y Lu, Richa Gupta, Adam Aguirre-Ducler, et al.Journal for Immunotherapy of Cancer|October 23, 2021
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditisSarah Boughdad, Sofiya Latifyan, Craig Fenwick, et al.Journal for Immunotherapy of Cancer|October 26, 2021
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacyYiqi Xu, Zhenyue Gao, Ruxin Hu, et al.Journal for Immunotherapy of Cancer|October 26, 2021
Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growthAnne Marijne Heeren, Jossie Rotman, Sanne Samuels, et al.Journal for Immunotherapy of Cancer|October 28, 2021
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancerPatricia Rich, R Brian Mitchell, Eric Schaefer, et al.Journal for Immunotherapy of Cancer|October 30, 2021
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastomaMitchell Evers, Marjolein Stip, Kaylee Keller, et al.Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.Journal for Immunotherapy of Cancer|October 19, 2021
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumorsChia-Ing Jan, Shi-Wei Huang, Peter Canoll, et al.Pageof 424